Derivatives marketplace CME Group could end up being a competitor in the U.S. for Coinbase’s crypto derivatives business, according to Owen Lau, a research analyst at Oppenheimer. CME told Oppenheimer on an earnings call that it has an edge in bitcoin derivatives given its offerings across many asset classes, its risk management experience and its highly regulated platform. Still, Coinbase’s customer base can help the exchange “draw trading volume and create [a] deep liquidity pool,” noted Lau, who has an outperform rating on Coinbase’s stock.
Related posts
-
XRP Price Gears Up: Is a Major Move on the Horizon?
XRP price is holding the $0.500 support zone. The price is consolidating and aiming for a... -
Kraken Launches Licensed Broker Offering for Australian Wholesale Clients, Expanding Access to Crypto-Based Derivatives
Kraken has announced the launch of a licensed broker... -
Dogecoin (DOGE) Poised for a Move: Will It Start a Fresh Increase?
Dogecoin started a downside correction from the $0.180 zone against the US Dollar. DOGE tested $0.1420...